BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...
Please provide your email address to receive an email when new articles are posted on . Half of the collected syringes grew at least one bacterial pathogen. Many syringes also tested positive for ...
Schreiner MediPharm expands its Needle-Trap needle protection system to support syringes up to 5 ml, helping pharmaceutical ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
MIT researchers have developed a simple, low-cost technology to administer powerful drug formulations that are too viscous to be injected using conventional medical syringes. The technology, which is ...
SCHOTT Pharma will invest $371 million to build the first U.S. facility to manufacture prefillable polymer syringes in Wilson, North Carolina. The syringes are required to meet the need for deep-cold ...
Mainz, Germany-based pharmaceutical container and delivery system supplier Schott Pharma AG & Co. is investing $371 million in Wilson, N.C., for a plant to manufacture prefillable plastic syringes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback